Anthony Bunn
Corporate Secretary bei De Novo Pharmaceuticals Ltd.
Profil
Anthony John Bunn is currently working as a Secretary at De Novo Pharmaceuticals Ltd.
He previously worked as a Secretary at Sareum Holdings Plc.
Aktive Positionen von Anthony Bunn
| Unternehmen | Position | Beginn |
|---|---|---|
De Novo Pharmaceuticals Ltd.
 De Novo Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology De Novo Pharmaceuticals Ltd. discovers and develops drugs. It is a novel molecular structure generating drug discovery platform targeting pathogenic bacteria. The firm offers lower cost, rapid, lower molecular weights hits, novel, and patentable hit molecules. The company was founded by David Bailey, Iwan de Esch, and Philip Dean M on April 28, 1999 and is headquartered in London, the United Kingdom. | Corporate Secretary | 01.09.2000 |
Ehemalige bekannte Positionen von Anthony Bunn
| Unternehmen | Position | Ende |
|---|---|---|
| SAREUM HOLDINGS PLC | Corporate Secretary | 07.01.2022 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SAREUM HOLDINGS PLC | Miscellaneous |
| Private Unternehmen | 1 |
|---|---|
De Novo Pharmaceuticals Ltd.
De Novo Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology De Novo Pharmaceuticals Ltd. discovers and develops drugs. It is a novel molecular structure generating drug discovery platform targeting pathogenic bacteria. The firm offers lower cost, rapid, lower molecular weights hits, novel, and patentable hit molecules. The company was founded by David Bailey, Iwan de Esch, and Philip Dean M on April 28, 1999 and is headquartered in London, the United Kingdom. | Health Technology |
